Literature DB >> 22184484

Earlier age of onset in BRCA carriers-anticipation or cohort effect?: A Countercurrents Series.

S A Narod.   

Abstract

Year:  2011        PMID： 22184484      PMCID： PMC3224023          DOI： 10.3747/co.v18i6.973

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  15 in total

1.  The risk of breast cancer in women with a BRCA1 mutation from North America and Poland.

Authors:  Jan Lubinski; Tomasz Huzarski; Tomasz Byrski; Henry T Lynch; Cezary Cybulski; Parviz Ghadirian; Malgorzata Stawicka; William D Foulkes; Ewa Kilar; Charmaine Kim-Sing; Susan L Neuhausen; Susan Armel; Dawna Gilchrist; Kevin Sweet; Jacek Gronwald; Andrea Eisen; Bohdan Gorski; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2011-09-22       Impact factor: 7.396

2.  The interval between cancer diagnosis among mothers and offspring in a population-based cohort.

Authors:  Ora Paltiel; Yehiel Friedlander; Lisa Deutsch; Rebecca Yanetz; Ronit Calderon-Margalit; Efrat Tiram; Hagit Hochner; Micha Barchana; Susan Harlap; Orly Manor
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

3.  Hereditary retinoblastoma: delayed mutation or host resistance?

Authors:  E Matsunaga
Journal:  Am J Hum Genet       Date:  1978-07       Impact factor: 11.025

4.  Earlier age of onset of BRCA mutation-related cancers in subsequent generations.

Authors:  Jennifer K Litton; Kaylene Ready; Huiqin Chen; Angelica Gutierrez-Barrera; Carol J Etzel; Funda Meric-Bernstam; Ana M Gonzalez-Angulo; Huong Le-Petross; Karen Lu; Gabriel N Hortobagyi; Banu K Arun
Journal:  Cancer       Date:  2011-09-12       Impact factor: 6.860

5.  Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.

Authors:  J Gronwald; T Huzarski; B Byrski; K Medrek; J Menkiszak; A N Monteiro; P Sun; J Lubinski; S A Narod
Journal:  J Med Genet       Date:  2005-10-14       Impact factor: 6.318

6.  Anticipation in hereditary breast cancer.

Authors:  E Dagan; R Gershoni-Baruch
Journal:  Clin Genet       Date:  2002-08       Impact factor: 4.438

7.  Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

Authors:  Mary-Claire King; Joan H Marks; Jessica B Mandell
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

8.  Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy.

Authors:  C Tsilfidis; A E MacKenzie; G Mettler; J Barceló; R G Korneluk
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

9.  Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease.

Authors:  N G Ranen; O C Stine; M H Abbott; M Sherr; A M Codori; M L Franz; N I Chao; A S Chung; N Pleasant; C Callahan
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

10.  Genetic anticipation is associated with telomere shortening in hereditary breast cancer.

Authors:  Beatriz Martinez-Delgado; Kira Yanowsky; Lucia Inglada-Perez; Samuel Domingo; Miguel Urioste; Ana Osorio; Javier Benitez
Journal:  PLoS Genet       Date:  2011-07-28       Impact factor: 5.917
View more
  3 in total

1.  Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers.

Authors:  Albert Grinshpun; Naama Halpern; Roy Zvi Granit; Ayala Hubert; Tamar Hamburger; Yael Laitman; Einat Shacham-Shmueli; Yehudit Peerless; Eitan Friedman; Tamar Peretz
Journal:  Eur J Hum Genet       Date:  2018-01-10       Impact factor: 4.246

2.  Association of socioeconomic status with the clinical management and outcomes in young patients (≤35 years) diagnosed with breast cancer: A retrospective analysis.

Authors:  Zoe Birnbaum; Garrett Jones; Graal Diaz; Thomas Duncan; Javier Romero; Shawn Steen
Journal:  Ann Med Surg (Lond)       Date:  2022-09-02

3.  Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.

Authors:  Rodrigo Santa Cruz Guindalini; Andrew Song; James D Fackenthal; Olufunmilayo I Olopade; Dezheng Huo
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.